Scottsdale Research Institute is a Phoenix-based clinical trials site that is dedicated to advancing the state of medical care through rigorous research. SRI strives to conduct high quality, controlled scientific studies intended to ascertain the general medical safety and efficacy of cannabis and cannabis products and examine various forms of cannabis administration. SRI is currently conducting the only federally authorized study of medical cannabis for Post-Traumatic Stress Disorder (PTSD) for military veterans in the United States.
The following diseases or conditions are additional areas of interest for future funding and research:
- Substitution therapy for opioid dependence, benzodiazepine withdrawal etc.
- Agitation in Alzheimer's disease
- Severe appetite suppression, weight loss, and cachexia due to HIV infection and other medical conditions
- Chronic pain, particularly neuropathic pain
- Severe nausea and vomiting associated with cancer and its treatment
- Severe muscle spasticity caused by diseases such as multiple sclerosis
- Autism, Autism Spectrum Disorders and other pervasive developmental disorders.
SRI also seeks to highlight and raise awareness of current barriers to cannabis research caused by Drug War-era policies and legislation.
SRI does not encourage or sanction the social or recreational use of cannabis, but supports the expansion of research efforts to determine the applicability of cannabis as medicine for any conditions for which it might prove safe and effective.